HIA
PFE icon

HFM Investment Advisors’s Pfizer PFE Stock Holding History

HFM Investment Advisors’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$21.3K Sell
885
-261
-23% -$6.83K 0.01% 85
2026
Q1 		$32.2K Buy
1,146
+19
+2% +$506 0.01% 65
2025
Q4 		$28K Buy
1,127
+427
+61% +$10.8K 0.01% 71
2025
Q3 		$17.8K Buy
700
+12
+2% +$296 0.01% 69
2025
Q2 		$16.7K Buy
688
+55
+9% +$1.28K 0.01% 72
2025
Q1 		$16K Buy
+633
New +$16.6K 0.01% 66

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

HFM Investment Advisors's PFE Position: Q2 2026 in Review

HFM Investment Advisors reduced its Pfizer (PFE) stake by 23% in Q2 2026, selling an estimated $6.83K and leaving 885 shares worth $21.3K. The position accounts for 0.01% of the portfolio, ranked #85.

HFM Investment Advisors first reported a position in PFE in Q1 2025 and has held it in 6 quarters since. The position peaked at $32.2K in Q1 2026. 2,827 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • HFM Investment Advisors held 885 shares of Pfizer worth $21.3K as of Q2 2026.
  • HFM Investment Advisors sold 261 Pfizer shares in Q2 2026, an estimated $6.83K.
  • Pfizer made up 0.01% of HFM Investment Advisors's portfolio in Q2 2026, its #85 holding.
  • HFM Investment Advisors first reported a position in Pfizer in Q1 2025 and has held it in 6 quarters since.
  • HFM Investment Advisors's Pfizer position peaked at $32.2K in Q1 2026.
  • 2,827 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on HFM Investment Advisors's 13F filing for Q2 2026, filed 4 Aug 2026.